Medical Oxygen
The Delhi government has set up a web portal to supply oxygen to those in home isolation after being infected with the COVID19.
As India is battling for oxygen continuously since the beginning of second wave of Covid pandemic, the Delhi Government has initiated towards the smooth supply of oxygen to those in home isolation requiring oxygen. The Delhi government has set up a web portal to supply oxygen to those in home isolation after being infected with the COVID19.
The web portal — delhi.gov.in — will go live on Thursday. Those requiring oxygen can apply with a valid photo id, Aadhar card details, Covid positive report and other documents like CT scan report if available, an order by the Delhi government read.
District magistrates have been given the responsibility to identify “dedicated dealers/depots to distribute such cylinders to individuals who shall not be redirected to refilling plants under any circumstances”.
“The district magistrates shall ensure that adequate number of office personnel are assigned to scrutinise all incoming applications and issue e-passes quickly as time is of essence in such cases,” the order read.
The order said a provision of lump-sum allocation of oxygen (to be given through cylinders) for individuals, non-Covid hospitals, nursing homes , ambulances and SOS cylinders of Covid hospitals running on LMO had already been made against re-fillers with each district being assigned a re-filler.
Recognizing the increasing burden of non-communicable diseases (NCDs) and the pivotal role of improving understanding…
The BJP-led Delhi government on Saturday entered into an agreement with the Union health ministry…
In a one of its kind research, India is set to begin an inter-ministerial scientific…
As an ode to Dr. Samuel Hahnemann, the founder of homoeopathy, on his birth-anniversary on…
RJD president and former Bihar chief minister Lalu Prasad was on Wednesday taken to Delhi…
The Indian Society for Extracellular Vesicles (InSEV) successfully hosted its inaugural conference, EVOLVE 2025, from…